Physician profile
Ginger J Gardner
NPI 1144263765
$8,774.68
in general payments reported to CMS, 2019-2025
8 companies · $1,443 in 2025
The $1,443 reported for 2025 was more than what 75% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2021: $14.62 · 2022: $7,006 · 2023: $112 · 2024: $27.78 · 2025: $1,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,110 · Food and Beverage: $447 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,110.00 |
| Food and Beverage | $447.20 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $6,875.00 | 2022 | |
| Genmab U.S., INC. | $1,250.49 | 2025 | Epkinly |
| Medtronic, INC. | $278.93 | 2023-2025 | Truclear |
| Glaxosmithkline, LLC. | $145.77 | 2021-2022 | |
| Genentech USA, INC. | $105.00 | 2019 | |
| Clovis Oncology, INC. | $66.01 | 2019 | |
| Karyopharm Therapeutics INC. | $27.78 | 2024 | Xpovio |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.